The presence of tumor infiltrating lymphocytes (TIL) has been demonstrated as a positive prognostic marker in several cancer types.24 As the number of OVA‐specific CD8 T cells did not explain improved therapeutic efficacy of the DCVacc/VSV‐GP over the single DCVacc treatment, we next determined the number of TILs in tumor tissues 7 days after the second DCVacc and VSV‐GP single and combination treatments. Here, CD8A is linked to cancer.